Mortality patterns and disparities in primary malignant brain neoplasms among U.S. adults aged ≥75 years: A 25-year retrospective analysis.

S Sarim Hassan Shahab (Nishtar Medical University, Multan, Punjab, Pakistan) A Abubakar Nazir (The Jewish Hospital- Mercy Health, Cincinnati, Ohio, United States) S Syeda Malika Naqvi (Nishtar Medical University, Multan, Pakistan) I Irza Shaikh (Peoples University of Medical and Health Sciences, Nawabshah, Pakistan) H Hadia Ghazala Masood (Nishtar Medical University, Multan, Pakistan) M Minahil Zahid (Punjab University College of Pharmacy, University of the Punjab, Lahore, Pakistan) I Imran Naqvi (The Jewish Hospital, Cincinnati, OH) A Abdul Haseeb Shehzad (The Jewish Hospital, Cincinnati, OH) F FNU Sawaira (5Peshawar Girls Medical College, Peshawar, Peshawar, Pakistan)

Abstract

e14064 Background: Primary malignant neoplasms of the brain disproportionately affect older adults, yet population-level mortality patterns among individuals aged ≥75 years remain insufficiently characterized. This study aims to evaluate temporal trends and demographic disparities in mortality due to primary malignant brain neoplasms among U.S. adults aged ≥75 years. Methods: Mortality data were obtained from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) Multiple Cause of Death database for adults aged ≥75 years. Primary malignant brain neoplasms were identified using ICD-10 code (C71), and age-adjusted mortality rates (AAMR) were calculated per 100,000 population. Temporal trends were evaluated using Joinpoint regression to estimate average annual percent change (AAPC) with 95% confidence intervals. Results: Between 1999 and 2023, brain neoplasms among adults ≥75 years led to 101,761 deaths, with the most deaths being recorded at the decedent's home (49.28%). The AAMR rose from 19.9 in 1999 to 22.3 in 2023 with an associated AAPC of 0.59 (p < 0.000001). In 1999, men had an AAMR of 24.9, while women had an AAMR of 16.88. In 2023 men had an AAMR of 27.20, while women had an AAMR of 18.65 (AAPC: 0.53; p < 0.000001 and AAPC: 0.46; p = 0.000038 for men and women respectively). Non-Hispanic White individuals had an AAMR of 24.19 (AAPC: 0.74; p < 0.000001) in 2023, which was almost twice as high as the AAMR of Non-Hispanic Black individuals, who experienced an AAMR of 12.12 in 2023 (AAPC: 0.52; p < 0.027657). This was followed by Hispanic or Latino individuals with an AAMR of 11.57 in 2023 (AAPC:1.26; p = 0.000483). States with the highest AAMRs included South Dakota (27.38). Arkansas (24.97) and Nebraska (24.89); states with the lowest AAMRs included Hawaii (10.65), District of Columbia (12.62) and New York (18.04). Geographically, the South had the highest AAMR of 23.08 in 2023 (AAPC: 0.48; p=0.000046), while the Northeast had the lowest AAMR of 19.99 in 2023 (AAPC: 0.81; p=0.000049). Conclusions: Mortality due to primary malignant brain neoplasms among U.S. adults aged ≥75 years has shown a sustained and statistically significant increase from 1999 to 2023, underscoring a growing public health burden in this rapidly expanding age group. Persistent disparities by sex, race/ethnicity, geography, and state highlight inequities in risk, access to care, and outcomes. Targeted strategies focusing on early recognition, equitable access to specialized neuro-oncologic care, and region-specific interventions are essential to address the rising mortality and demographic disparities. Metric Findings Deaths 101,761; 49% home AAMR 19.9→22.3; AAPC 0.59 Disparities Men, Non-Hispanic White highest Region South highest; Northeast lowest States South Dakota, Arkansas, Nebraska had the highest burden

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (9)

S

Sarim Hassan Shahab

Nishtar Medical University, Multan, Punjab, Pakistan

A

Abubakar Nazir

The Jewish Hospital- Mercy Health, Cincinnati, Ohio, United States

S

Syeda Malika Naqvi

Nishtar Medical University, Multan, Pakistan

I

Irza Shaikh

Peoples University of Medical and Health Sciences, Nawabshah, Pakistan

H

Hadia Ghazala Masood

Nishtar Medical University, Multan, Pakistan

M

Minahil Zahid

Punjab University College of Pharmacy, University of the Punjab, Lahore, Pakistan

I

Imran Naqvi

The Jewish Hospital, Cincinnati, OH

A

Abdul Haseeb Shehzad

The Jewish Hospital, Cincinnati, OH

F

FNU Sawaira

5Peshawar Girls Medical College, Peshawar, Peshawar, Pakistan